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ABSTRACT
Burkholderia pseudomallei, the causative agent of melioidosis, is an intracellular pathogen capable of invading and 
multiplying in both phagocytic and non-phagocytic cells. Infection results in an inflammatory response involving 
production of both pro- and anti-inflammatory cytokines. The cellular mechanism regulating this response, believed to 
play an important role in the pathogenesis of meliodoisis, is not fully understood. In recent years, glycogen synthase 
kinase-3 (GSK3) has been shown to assume a pivotal role in regulating production of these cytokines. Bacterial infection 
of host cells activates Toll-like receptors (TLRs) and results in the phosphorylation of GSK3β through activation of the 
phosphoinositide 3-kinase (PI3K) pathway. In this study, we investigated the effects of GSK3 inhibition in regulating b. 
pseudomallei-induced inflammatory response in macrophages and A549 epithelial lung cells. Our results showed that 
infection of cells with B. pseudomallei resulted in the increase of anti-inflammatory cytokine, IL-10 and pro-inflammatory 
cytokine, TNF-α. Pre-treatment of infected cells with GSK3 inhibitors caused further increase in the level of IL-10 but 
a significant decrease in TNF-α. These changes corresponded with the detection of phosphorylated GSK3β in infected 
cells treated with LiCl; suggesting that modulation of inflammatory response in B. pseudomallei infection involves 
phosphorylation of GSK3β (Ser 9). This could explain our observations from the invasion assays that pre-treatment of 
B. pseudomallei-infected cells with GSK3 inhibitors resulted in decreased intracellular replication of bacteria within 
macrophages and A549 epithelial lung cells. In summary, our results demonstrate a regulatory function of GSK3 in the 
modulation of cytokine levels during B. pseudomallei infection.
Keywords: Burkholderia pseudomallei; glycogen synthase kinase-3; inflammation; macrophage; melioidosis
ABSTRAK
Burkholderia pseudomallei, patogen penyebab melioidosis merupakan bakteria intrasel yang mampu menginfeksi 
dan mengganda dalam sel fagosit serta sel bukan fagosit. Infeksi mengakibatkan respons inflamasi yang melibatkan 
penghasilan sitokin pro- dan anti-inflamasi. Mekanisme pengawalan respons tersebut yang dipercayai memainkan 
peranan penting dalam patogenesis melioidosis masih belum difahami sepenuhnya. Glikogen sintase kinase-3 (GSK3) 
kini diketahui mempunyai peranan utama dalam pengawalan penghasilan sitokin pro- dan anti-inflamasi. Infeksi sel 
hos oleh bakteria mengaktifkan reseptor Toll-like (TLR) dan mencetuskan pemfosfatan GSK3β melalui pengaktifan tapak 
jalan fosfoinositid-3-kinase (PI3K). Kami mengkaji kesan perencatan GSK3 dalam pengawalan respons inflamasi yang 
diaruh oleh B. pseudomallei dalam makrofaj dan sel epitelium peparu A549. Hasil yang kami peroleh menunjukkan 
peningkatan penghasilan sitokin anti-inflamasi, IL-10 dan sitokin pro-inflamasi, TNF-α dalam sel diinfeksi B. pseudomallei. 
Pra-perlakuan sel terinfeksi dengan perencat GSK3 menyebabkan aras sitokin IL-10 meningkat dengan lebih tinggi 
tetapi penghasilan TNF-α berkurangan secara signifikan. Perubahan aras sitokin IL-10 dan TNF-α berpadanan dengan 
pengesanan GSK3β terfosfat dalam sel diinfeksi yang diberi perlakuan LiCl. Ini mencadangkan bahawa modulasi respons 
inflamasi semasa infeksi B. pseudomallei melibatkan pemfosfatan GSK3β (Ser 9). Ini juga menjelaskan cerapan daripada 
asai penaklukan yang menunjukkan pra-perlakuan perencat GSK3 menyebabkan pengurangan penggandaan bakteria 
intrasel dalam makrofaj dan sel epitelium peparu A549 yang diinfeksi B. pseudomallei. Secara keseluruhan hasil kami 
menunjukkan GSK3 terlibat dalam modulasi aras sitokin semasa sel diinfeksi B. pseudomallei.
Kata kunci: Burkholderia pseudomallei; glikogen sintase kinase-3; inflamasi; makrofaj; melioidosis
InTRoDUCTIon
Burkholderia pseudomallei, a free-living Gram-negative 
bacterium is the causative agent for the disease melioidosis 
in humans. The disease is a significant cause of morbidity 
and mortality whenever it strikes. B. pseudomallei is known 
to secrete various extracellular products; such as exotoxin, 
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which have been implicated in the pathogenesis of this 
disease (Ismail et al. 1987). Because of its high virulence, 
B. pseudomallei is currently considered as a category b 
bio-terrorism agent. Commonly encountered in the tropical 
environment, especially soil, mud and surface water, it can 
cause varying manifestations of the disease; ranging from 
asymptomatic form to fulminating deadly form (White 
2003; Wiersinga et al. 2006). It is notorious in infecting 
people with high risk conditions such as diabetics and other 
immuno-compromised hosts (Valvano et al. 2005). 
 The lipopolysaccharide (LPS) of B. pseudomallei has 
been demonstrated to be weak stimulators of macrophages 
(Arjcharoen et al. 2007; ho et al. 1997; Matsuura et al. 
1996). Compared with B. thailandensis, a close relative 
that rarely cause disease, B. pseudomallei produce 
lower concentrations of inflammatory cytokines TnF-α, 
IL-6 and IL-10 from both stimulated human and murine 
macrophages in vitro (novem et al. 2009). offering to 
explain the difference in the virulence of these two closely-
related bacteria, novem et al. (2009) suggest the more 
efficient stimulation of cytokine release by non-pathogenic 
B. thailandensis which makes them more susceptible to 
killing by the host innate immune system. on the other 
hand, the pathogenic B. pseudomallei are able to evade 
killing by macrophages through their strategic lowering of 
the cytokine concentration. To achieve this, their LPS are 
structurally modified to act as weak macrophage activators. 
All these suggest the role of inflammatory cytokines in the 
pathogenesis of B. pseudomallei.
 In Francisella tularensis infection, the manifestation 
of sepsis has been associated with an over-production of 
pro-inflammatory cytokines including IL-6, IL-12 and TnF-
alpha (Cole et al. 2008). Further, it has been shown that LPS 
is capable of activating the phosphatidylinositol 3-kinase 
(PI3K) pathway which plays a central role in regulating 
host inflammatory response (Wang et al. 2010). LPS has 
also been shown to induce phosphorylation of glycogen 
synthase kinase 3 (GSK3), suggesting the role of this 
enzyme in innate immune response (ohtani et al. 2008). 
Among the effector molecules of the PI3K pathway, the 
serine/threonine kinase, GSK3 has been identified as central 
in regulating the production of pro- and anti-inflammatory 
cytokines. This enzyme exists in two isoforms; GSK3α 
(molecular weight 51 kDa) and GSK3β (molecular weight 
47 kda). 
 Although GSK3 was first identified as one of the key 
enzymes involved in glycogen metabolism (Cohen & 
Frame 2001; Embi et al. 1980), it was subsequently shown 
to be involved in a variety of cellular processes including 
membrane-to-nucleus signaling, gene transcription, 
translation, cytoskeletal organization, cell cycle progression 
and cell apoptosis (Dugo et al. 2006; Jope et al. 2007). our 
present study seeks to investigate the role of GSK3 in the 
intracellular survival of B. pseudomallei in macrophages 
and lung epithelial cells that may relate to host regulatory 
control of cytokine production.
MATERIAlS AnD METhoDS
BACTERIAl STRAIn AnD CUlTURE
B. pseudomallei strain D286 was a kind gift from Prof. 
Sheila nathan (Pathogen Laboratory, School of biosciences 
& Biotechnology, Faculty of Science and Technology, The 
national University of Malaysia). A single colony with a 
dry, wrinkled appearance was grown overnight in brain 
heart infusion broth (bhIb) at 37°C. The culture was 
sub-cultured at 1:50 in bhIb and grown to mid-log phase. 
Absorbance readings were measured at 600 nm using 
UV-spectrophotometer and the colony forming unit (CFU) 
estimated from a pre-calibrated standard curve.
CEll CUlTURE
human monocyte-like U937 cell line (ATCC no. CRl-
1593.2) was purchased from American Type Culture 
Collection. Cells were maintained in RPMI 1640 cell culture 
medium supplemented with 10% fetal bovine serum, 2 
mM l-glutamine, 1 mM sodium pyruvate and 25 mM 
hEPES (complete medium). Prior to experiments, cells were 
induced to differentiate into macrophages using a total of 1 
× 105 U937 cells seeded into a 24-well tissue culture plate 
and incubated with 10 ng/ml phorbol myristate acetate 
(PMA) at 37°C in 5% Co2 for 48 h. After induction, the 
medium was removed and monolayer cells were washed 
with phosphate-buffered saline (PbS) to remove traces of 
PMA. 
 Cryo-preserved stock of human lung carcinoma cell 
culture A549 (ATCC no. CCl-185) was kindly provided 
by Prof. Sheila nathan. Culture was maintained in 
Dulbecco’s modified eagle medium (dMEM) supplemented 
with 10% fetal bovine serum, 4500 mg/l D-glucose, 2 mM 
l-glutamine and 25 mM hEPES buffer (37°C, 5% Co2).
PhARMAColoGICAl InhIBIToRS
GSK3 inhibitors, lithium chloride (liCl) and Sb216763 
were purchased from Sigma. Sb216763 was reconstituted 
in dimethyl sulfoxide and stored at -20°C until used. 
InVASIon ASSAy
U937 cells (1×105) were seeded into 24-well cell culture 
plates and induced with PMA as described above. A 
suspension of A549 epithelial cells in serum-free dMEM 
was seeded into 12-well plates at a density of 1 × 105 cells/
ml. Cells were pre-treated with liCl (1, 5, 10 and 20 mM) 
or Sb216763 (2.5, 5, 10 and 20 μM) for 1 h (5% Co2 at 
37°C) prior to incubation with B. pseudomallei. 
 Bacterial invasion assays were performed according 
to the method of Elsinghorst (1994). Bacterial culture was 
prepared using B. pseudomallei D286 culture at mid-log 
phase which was pelleted by centrifugation at 14000 rpm 
for 1 min, washed with PbS and resuspended in cell culture 
medium. The bacterial suspension was then added to the 
cells (in the presence of GSK3 inhibitors) at MoI of 10:1. 
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After 2 h incubation in 5% Co2 at 37°C, the monolayers 
were washed with PbS and further incubated for 2 h in 
culture medium containing kanamycin (250 μg/ml). The 
monolayers were washed with PbS and lysed with 0.1% 
Triton X-100 at various time points during incubation with 
kanamycin (time zero was taken 15 min after incubation 
in antibiotic-containing medium) and intracellular bacteria 
quantified by drop-plating of the serially-diluted lysate on 
Ashdown agar plates. All invasion assays were performed 
in triplicates.
WESTERn BloT
At the various time intervals (0, 30, 60 and 120 min) after 
incubation with kanamycin, the cells were lysed in buffer 
containing 50 mM Tris hCl, 150 mM naCl, 1% Triton 
X-100, phosphatase and protease inhibitors (1 mM EDTA, 
1 mM EGTA, 0.5 mM na3Vo4, 0.5 mM PMSF, 1 μg/ml 
aprotinin, 5 μg/ml leupeptin and 1 mM naF). Equivalent 
amounts (40 μg) of proteins were separated through 12% 
polyacrylamide gels and then electro-transferred onto 
nitrocellulose membrane (Amersham hybond-ECL, GE 
healthcare, USA). The membrane was blocked with 3% bSA 
for 1 h before overnight incubation with rabbit polyclonal 
antibody to GSK3β or pGSK3β (Ser9). Blots were then 
incubated with hRP-conjugated anti-rabbit IgG (Promega, 
USA). Detection of immune-reactive bands was carried 
out using ECL western blot detection reagents (Thermo 
Scientific, USA). 
CyToKInE AnAlySIS
The levels of IL-10, IL-12 and TnF-α in the supernatants 
of cell culture infected with B. pseudomallei (0, 30, 60 
and 120 min post-infection) and pre-treated with GSK3 
inhibitors was determined using instructions provided with 
the enzyme-linked immunosorbent assay kits (IL-10/IL-12/
TnF-α ELISA kit, eBioscience) employed. 
RESUlTS
MUlTIPlICATIon oF B. pseudomallei In CELLS
B. pseudomallei is a facultative intracellular bacterium 
which can survive and multiply in both phagocytic and 
non-phagocytic cells (Utaisincharoen et al. 2004). B. 
pseudomallei is able to invade non-phagocytic cells 
including heLa, Cho, A549 and Vero (Kespichayawattana 
et al. 2004). Cells were infected with B. pseudomallei at an 
MoI of 10:1 in order to assess the viability and multiplication 
of bacteria within U937 macrophages and A549 epithelial 
cells. Evaluation of the initial colony forming unit (CFU) 
of bacteria which successfully invaded U937 macrophages 
showed that 2.8% of the original inoculum entered 
macrophages. This is comparable with the data reported 
in J774A.1 and RAW264.7 macrophages infected by B. 
pseudomallei isolates (Gong et al. 2011; Wand et al. 2011). 
The number of intracellular B. pseudomallei increased up 
until 120 min after kanamycin treatment (3.39 × 105 CFU/
ml) signifying multiplication of B. pseudomallei within 
the phagocytic cells during this period (Figure 1). In the 
case of the human respiratory epithelial cell line A549, 
the invasive capacity of B. pseudomallei was reported 
to be significantly greater than that of B. thailandensis 
(Kespichayawattana et al. 2004). The number of bacteria 
that invaded epithelial cells was 3-4% of the bacterial 
inoculum employed. An exponential increase of up to 
2.8 × 107 CFU/ml of intracellular bacteria was observed 
in epithelial cells 2 h post-infection (Figure 1). Studies 
by Phewkliang et al. (2010) showed that percentage 
internalisation of B. pseudomallei into human epithelial 
cell line was 1.2% for B. pseudomallei 1026b and 3.6% 
for B. pseudomallei SR1015. The invasion data obtained 
here with B. pseudomallei D286 showed percentage 
invasion obtained was comparable with that established 
by other researchers and reiterate various reports that 
B. pseudomallei can invade and replicate intracellularly 
within eukaryotic cells.
MUlTIPlICATIon oF B. pseudomallei In CEllS In ThE 
PRESEnCE oF GSK3 InhIBIToRS
To evaluate how GSK3 inhibitors affected replication of 
B. pseudomallei in cells, bacterial CFUs in phagocytic and 
non-phagocytic cells pre-exposed to various concentrations 
of LiCl or Sb216763 were determined at 0, 60 and 120 min 
post-kanamycin treatment. neither liCl nor Sb216763 
affected the viability of B. pseudomallei, macrophages or 
epithelial cells at the tested concentrations. 
 Pre-treatment with liCl (Figure 2) or Sb216763 (Figure 
3) had no effects on internalisation of B. pseudomallei in 
macrophages and epithelial cells based on the CFU/ml 
of bacteria in treated and non-treated cells at 0 min post-
infection. 
 In macrophages pre-treated with 10 mM and 20 mM 
liCl (Figure 2), the number of intracellular bacteria at 60 
min post-infection was only 33 and 37%, respectively, 
compared with the control. Similarly, the number of 
intracellular bacteria at 120 min post-infection was 
lowered to 10 and 20 mM liCl pre-treatment to 40 and 
39%, respectively. Pre-treatment of macrophages with the 
GSK3 inhibitor Sb216763 also significantly lessened the 
multiplication of bacteria within macrophages to about 50% 
at 60 min post-infection for both 10 and 20 μM Sb216763 
(Figure 3). At 120 min post-infection, the multiplication 
of intracellular bacteria was attenuated to 30, 65 and 47%, 
respectively, in macrophages pre-treated with Sb216763 
at concentrations of 5, 10 and 20 μM. Taken together, 
this showed that pre-treatment with GSK3 inhibitors (LiCl 
or Sb216763) suppressed multiplication of intracellular 
bacteria in macrophages even though both inhibitors did 
not have any effect on bacterial invasion. In epithelial 
cells similarly pre-treated with either liCl or Sb216763, 
attenuation of intracellular bacterial multiplication was 
also observed within the concentrations tested at both 60 
and 120 min post-infection time points.
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FIGURE 2. Intracellular CFU of B. pseudomallei in U937 macrophages and A549 epithelial cells pre-treated with liCl. Cells were pre-
incubated with liCl or vehicle (control) for 1 h prior to infection with B. pseudomallei at an MoI of 10 bacteria per cell. Cells were 
washed and further incubated in medium containing kanamycin (250 μg/ml) for 0 h, 1 h and 2 h (time zero was taken 15 min after 
incubation with antibiotic-containing medium). Cells were then lysed with 0.1% Triton X-100 and intracellular bacteria were quantified 
by serial dilution plating of the lysate. Results shown are combined from two independent sets of experiments. Each experiment was 
done in triplicates. Statistical analysis was performed using a Student’s t-test (*p< 0.05; **p<0.01; ***p<0.001) 
FIGURE 1. Intracellular CFU of B. pseudomallei D286 in U937 macrophages and epithelial cells. 
Cells were incubated with B. pseudomallei at an MoI of 10:1 for 2 h at 37˚C in 5% Co2 to allow 
bacterial entry. Cells were washed and  further incubated in medium containing kanamycin 
(250 μg/ml) for up to 120 min. The bacterial count was enumerated at various time points post-
infection by cell lysis and plating onto Ashdown agar. one representative experiment out of two 
independent experiments is shown. Each experiment was done in triplicates
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 In summary, our results from the invasion assays 
showed that at the concentrations tested, pre-treatment of 
cells with GSK3 inhibitors (LiCl and Sb216763) attenuated 
multiplication of the intracellular B. pseudomallei in 
macrophages and in A549 epithelial lung cells.
PhoSPhoRylATIon oF GSK3β In B. pseudomallei
-InFECTED CEllS 
The phosphorylation state of GSKβ in cells was determined 
2 h post-infection by western blotting. Phosphorylated 
GSK3β (Ser 9) was not observed in non-infected cells 
(Figure 4). however, in B. pseudomallei-infected cells, 
phosphorylated GSK3 (Ser 9) was detected in macrophages 
and A549 epithelial cells as early as 15 min and persisted 
through 120 min post-infection. The intensity of the 
phosphorylated GSK3 (Ser 9) band was more pronounced 
in cells that were pre-treated with GSK3.
CyToKInE PRoDUCTIon In B. pseudomallei-InFECTED CEllS 
In ThE PRESEnCE oF GSK3 InhIBIToRS
Pathogenic infection is commonly associated with 
inflammatory cytokine production in the host. In lieu 
of this, levels of anti-inflammatory cytokine, IL-10; and 
pro-inflammatory cytokines, TnF-α and IL-12 secreted by 
phagocytic and non-phagocytic cell lines in response to B. 
pseudomallei infection were determined using cytokine-
specific ELISA kits (ebiosciences, USA). B. pseudomallei 
infection gradually increased the levels of IL-10 and TnF-α 
in macrophages up to 17- and 13-times, respectively, at 
2 h post-infection compared with non-infected control 
macrophages (Figure 5). B. pseudomallei-infected 
epithelial cells also showed increased in IL-10 and TnF-α 
levels (up to 1.8- and 5.2-times, respectively). however, 
no significant changes in IL-12 were detected during 
early infection of B. pseudomallei in both macrophages 
and epithelial cells. This is because while other cytokines 
involved in innate immune response are detected early 
during bacterial invasion, IL-12 was produced relatively 
later in the course of infection (Miettinen et al. 1998). 
 Pre-treatment of macrophages with either liCl or 
Sb216763 increased the level of IL-10 cytokine by about 
50- and 44-times, respectively, compared with non-infected 
control macrophages (Figure 6). TnF-α cytokine level was 
7.6- and 5.6-times more with pre-treatment of infected 
macrophages with either liCl or Sb216763, respectively, 
as compared with non-infected control macrophages. This 
change in TnF-α level however, was significantly lower 
compared with infected cells. Pre-treatment of macrophages 
with GSK3 inhibitors had no effects on IL-12 level.
 Similar observations in cytokine levels were 
detected in epithelial cells pre-incubated with GSK3 
FIGURE 3. Intracellular CFU of B. pseudomallei in U937 macrophages and A549 epithelial cells pre-treated with Sb216763. Cells were 
pre-incubated with Sb216763 or vehicle (control) for 1 h prior to infection with B. pseudomallei at an MoI of 10 bacteria per cell. 
Cells were washed and further incubated in medium containing kanamycin (250 μg/ml) for 0 h, 1 h and 2 h (time zero was taken 
15 min after incubation with antibiotic-containing medium). Cells were then lysed with 0.1% Triton X-100 and intracellular bacteria 
were quantified by serial dilution plating of the lysate. Results shown are combined from two independent sets of experiments. Each 
experiment was done in triplicates. Statistical analysis was performed using a Student’s t-test (*p< 0.05; **p<0.01; ***p<0.001) 
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FIGURE 4. Serine 9 phosphorylation of GSK3β in B. pseudomallei-infected macrophages and epithelial 
cells in the presence or absence of liCl. The cells were pre-incubated with liCl or vehicle for 1 h before 
infection with B. pseudomallei at MoI of 10:1. Cells were washed and further incubated in medium 
containing kanamycin (250 μg/ml). At 15, 30, 60 and 120 min post-infection, cells were lysed and 
phosphorylation of GSK3β was determined by immunoblotting
(A)  U937 macrophages (B)  A549 epithelial cells
FIGURE 5. levels of cytokines in macrophages and epithelial cells during infection with B. pseudomallei. Cells were 
infected with B. pseudomallei at MoI of 10 bacteria per cell. Cells were washed and further incubated in medium containing 
kanamycin (250 μg/ml) for 15, 30, 60 and 120 min and the levels of IL-10, TnF-α and IL-12 in the culture 
supernatants were analysed by ELISA. Control cells consisted of uninfected, untreated normal cells
(A)  U937 macrophages
(B)  A549 epithelial cells
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inhibitors. Pre-treatment of epithelial cells with liCl or 
Sb216763 resulted in further increase in levels of IL-10 
(3.2- and 3.3-times, respectively). TnF-α cytokine level 
was 1.4-  and 2.3-times more with the pre-treatment of 
infected macrophages with either liCl or SB216763, 
respectively, as compared with non-infected control 
epithelial cells (Figure 6). This change in TnF-α level 
is significantly lower compared with the infected cells. 
however, no significant changes in IL-12 was detected 
during infection or with pre-treatment of A549 cells with 
GSK3 inhibitors.
dISCUSSIon
During infection by Gram-negative bacteria, the host 
innate immune response is triggered by lipopolysaccharide 
(LPS), the major outer membrane component of such 
bacteria, resulting in the production of both pro- and anti-
inflammatory cytokines needed to curb invasion (Elson et 
al. 2007). LPS, however, may also result in over-stimulation 
of cytokine release leading to sepsis primarily responsible 
for high mortality in acute melioidosis. Results from the 
cytokine level studies in the present study supports the 
notion that proper balance of pro- and anti-inflammatory 
cytokines is important for successful invasion of the host 
by B. pseudomallei. 
 host recognition of B. pseudomallei involves 
transmembrane receptors, specifically TlR2 and TlR4 
(hii et al. 2008; West et al. 2008; Wiersinga et al. 2007). 
The underlying cellular mechanisms which regulate the 
inflammatory cytokine response following TlR stimulation 
is believed to be mediated through GSK3. 
 Activation of the PI3K pathway by TlR2 agonists gave 
differential effects on the production of anti-inflammatory 
IL-10 and the pro-inflammatory IL-12 cytokines (Fukao et 
al. 2002). Inhibition of the PI3K activity was reported to 
reduce IL-10 production but increase IL-12 levels. This is 
however not a universal phenomenon for bacterial infection 
of host cells.
 our investigations revealed that B. pseudomallei 
infection caused an increase in the release of anti-
inflammatory cytokines IL-10 and TnF-α in macrophages. 
Inhibition of GSK3 activity further increased IL-10 
production. This observation suggests a beneficial role 
for GSK3 inactivation in ensuring the ability of the host 
to control an overproduction of cytokines during B. 
pseudomallei infection. IL-10 has been reported to be 
capable of preventing cytokine overproduction in response 
to both microbial infections and cancer development (Chan 
et al. 2009). Studies on the role of GSK3 activity using other 
pathogens also appear to concur with our observations. 
GSK3 inhibition protected mice from lethal infection with 
Francisella tularensis by increasing production of anti-
inflammatory cytokines and reducing pro-inflammatory 
cytokines (Zhang et al. 2009). For enhanced survival in 
the host, Mycobacterium infection resulted in inhibition of 
host GSK3 activity that led to increased IL-10 production 
(Chan et al. 2009). Specific inhibition of GSK3 in bCG-
infected human macrophage cells resulted in increased 
production of IL-10 which was also a potent suppressor of 
IFn-γ production (Chan et al. 2009). These investigations 
suggest that GSK3 acts as a negative regulator of anti-
inflammatory cytokine IL-10 production in response to 
bacterial invasion.
 our present study showed that inhibition of GSK3 led 
to significant reduction of TnF-α secretion by macrophages 
and epithelial cells. Similar observations have been 
documented for Staphylococcus aureus and F. tularensis 
infections upon GSK3 inhibition (Cheng et al. 2009; 
Zhang et al. 2009). The pathological role of TnF-α have 
attracted much attention in recent years. Exogenous and 
endogenous factors from bacteria, viruses and parasites 
are known to stimulate production of TnF-α and other 
cytokines. lipopolysaccharide from bacterial cell walls is 
(A)  U937 macrophages (B)  A549 epithelial cells
FIGURE 6. levels of cytokines in macrophages and epithelial cells in the presence or absence of GSK3 inhibitors during infection 
of B. pseudomallei. Cells were pre-incubated with liCl, SB216763 or vehicle for 1 h before infection with B. pseudomallei at MoI 
of 10:1. Cells were washed and further incubated in medium containing kanamycin (250 μg/ml) for 2 h and the levels of IL-10, 
TnF-α and IL-12 in the culture supernatants were analysed by ELISA. Control cells consisted of uninfected, untreated normal cells
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an especially potent stimulus for TnF-α synthesis (Tracey 
& Cerami 1994).
 hence, TnF-α can bring about beneficial effects for the 
host in inflammation and in protective immune responses 
against a variety of infectious pathogens. on the other 
hand, depending on the levels produced and released during 
infection, TnF-α can also exert host-damaging effects 
(Pfeffer 2003). In melioidosis, it is tempting to speculate a 
scenario depicting the role of TnF-α during local infection 
or inflammation. Produced by macrophages, low levels 
of TnF-α could act to enhance immune responsiveness. 
It can stimulate blood-vessel growth, increase energy 
mobilization, induce the release of other cytokines and 
promote wound-healing (Dalmas et al. 2012). But when 
overwhelming infection occurs, as in the case of acute 
melioidosis, large quantities of TnF-α could reach the 
circulation and cause septicemic shock. If a persisting 
infection develops and TnF-α is chronically secreted, it 
could result in death. Future studies will undoubtedly 
advance our understanding of these effects of TnF-α and 
that of the other cytokines. The development of novel 
therapies for inflammation and septic shock in melioidosis 
may be based on such advances.
 our results, however, painted a different picture of 
prototypical pro-inflammatory cytokine IL-12. Infection 
with B. pseudomallei failed to show a significant increase 
in the production of pro-inflammatory cytokine IL-12 
during early stage of infection. Inhibition of GSK3 also 
failed to exert any impact on the secretion of IL-12. We 
offer the following possible explanation for this unexpected 
observation in our study. While other cytokines involved 
in innate immune response are detected early during 
bacterial invasion, IL-12 was produced relatively later 
in the course of infection (Miettinen et al. 1998). Indeed 
it has been demonstrated by others that LPS-stimulated 
human macrophages showed significant increase in IL-12 
production after 24 h (Coant et al. 2011; Miettinen et al. 
1998; Zhang et al. 2009). It is possible that in our study, 
IL-12 production was not pronounced because this specific 
inflammatory cytokine did not play a significant role in 
the early response of infection by B. pseudomallei. IL-12, 
however, may be crucial in the adaptive immune response. 
It is known to be primarily secreted by the peripheral 
lymphocytes after infection, particularly by B-cells and to 
a lesser extent by T-cells (Morris et al. 1994). here, in the 
acquired immune response, IL-12 is involved probably in 
the selection of host immunoglobulin isotypes (Morris et 
al. 1994). For instance, at picomolar concentrations, IL-12 
has been shown to markedly inhibit the synthesis of IgE 
by peripheral blood mononuclear cells (Brunda 1994). 
 our present study also revealed that inhibition of GSK3 
activity significantly reduced the intracellular survival of 
B. pseudomallei in macrophages and epithelial cells. This 
suggests that B. pseudomallei requires intact host GSK3 
activity for its successful invasion. Such requirement has 
also been reported in other infection models including 
Salmonella typhimurium (duan et al. 2007), Yersinis 
pestis (Sauvonnet et al. 2002) and F. tularensis (zhang et 
al. 2009). Any attempt to provide some explanations for 
this reduced survival of bacterial pathogens in host cells 
with dysfunctional GSK3 activity would be speculative 
at this juncture. nonetheless, our data suggest two 
important points: the pro- and anti-inflammatory cytokine 
network could assume a diversity of biological functions 
to determine the course of B. pseudomallei infection 
and the regulation of the overlapping and synergistic 
effects between many different cytokines is critical in the 
protection against B. pseudomallei infection or causing 
tissue injury and death to infected host cells. 
 We postulate that the reduced survival of B. 
pseudomallei upon inhibition of GSK3 pathway may relate 
to the failure of this intercellular pathogen in establishing a 
replicative niche after its internalization by the host cells. 
once ingested, bacterial pathogens may undergo varying 
pathways to establish a replication niche for themselves. 
Some pathogens escape from being killed by the lysosomal 
enzymes in the phagocytic vacuoles by travelling along the 
‘end-to-end track’ formed by host cell microtubules to end 
up in affable cell compartments such as the endoplasmic 
reticulum (ER) and cell cytoplasm. here, they can safely 
and rapidly replicate to cause detrimental effects to the host 
cells and result in diseases. others employ actin-mediated 
mobility to escape from the vacuoles. The mechanism(s) 
employed by B. pseudomallei to delay lysosomal fusion 
and avoid killing by lytic enzymes and acidic ph remains 
unclear.
 Many pathogens interfere with the phosphorylation 
mechanism of the host to survive and cause disease 
(Kwok et al. 2007). A number of intracellular pathogens 
interfere with signaling pathway of the phophoinositide (PI) 
metabolism which is known to determine several crucial 
events during infection including membrane trafficking, 
actin rearrangement and cell survival (Duronio 2008; 
Krauß & haucke 2007; Toker & Cantley 1997; Weber et 
al. 2009). 
 Evidence has been accumulating to suggest the 
importance of PI metabolism in the internalization of 
pathogens to form phago-lysosomal vacuoles in the host 
cells. For instance, PI3K has been shown to play a role in 
the phagocytosis of many pathogens (Ireton et al. 1996; 
lindmo & Stenmark 2006; Toker & Cantley 1997; Weber 
et al. 2009). The initial contact and subsequent uptake of 
bacterial pathogens into the host cells is believed to be 
dependent on PI3K pathway and the ensuing downstream 
signaling in macrophages (Charpentier et al. 2009; Tachado 
et al. 2008). 
 It is thus quite plausible that B. pseudomallei has 
evolved as a pathogen that is dependent on the host cell 
phosphorylation pathways. It may have targeted and 
exploited the host phosphorylation system as part of 
its strategy to establish an environment beneficial for 
replication. hence, when the GSK3 activity was inhibited, 
processes known to be GSK3-regulated and crucial in 
host-pathogen encounter are disrupted. These processes 
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include cell motility, microtubule function, cell adhesion 
and inflammation; all are prerequisites to the ingestion 
and intracellular survival of the pathogen within the 
macrophage phagocytic vacuoles.
 In our attempt to understand the pathogenic 
mechanisms involved during invasion by this deadly 
bacteria, our team had previously probed into the 
cellular determinants deemed critical in the host defense 
against B. pseudomallei. Studies include the resistance 
of B. pseudomallei to the bactericidal action of normal 
human serum (Ismail et al. 1988), inhibition of protein 
and dnA synthesis by the bacterial exotoxin (Mohamed 
et al. 1989) and rapid killing of the bacteria by human 
polymorphonuclear leukocytes (Razak & Ismail 1982). 
While our previous investigations gave insights into the 
events occurring during the microbial-host cell interactions 
before the establishment of the disease, our present study 
focused on the events taking place relatively earlier in 
the infection process. The attenuation of intracellular 
multiplication of bacteria as a result of GSK3 inhibition 
leads us to speculate the following sequence of events 
taking place during early phase of infection by B. 
pseudomallei. Firstly, the pathogen-associated molecular 
patterns (PAMPs) of B. pseudomallei including LPS and lipid 
A are recognized by the TlR2 and TlR4 of the host cells 
(West et al. 2008). This is followed by over-production 
of pro-inflammatory cytokines if GSK3 is not inhibited. 
Under attack, this imbalance of pro- and anti-inflammatory 
cytokines renders the host more susceptible to developing 
the disease melioidosis.
ConClUSIon
To our knowledge, our study represents the first attempt 
to elucidate the role of GSK3 in B. pseudomallei infection. 
The results of our investigation brought to light the possible 
regulatory role of GSK3 in ensuring a proper balance 
between anti- and pro-inflammatory cytokine productions 
that must be met to avoid detrimental effects to the host 
cells and contribute to the progression of melioidosis. GSK3 
is thus crucial in the regulation of innate immune responses 
during B.pseudomallei infection. our initial study here 
suggests that GSK3 may be a target for novel therapeutic 
approaches aimed at managing acute and threatening 
stages of melioidosis. Inhibitors of GSK3, such as LiCl, 
for example, may be useful in controlling excessive pro-
inflammatory response to B. pseudomallei infection in 
advanced and life-threatening melioidosis.
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